Cancer peptides are short amino acid sequences that play an increasingly important role in oncology research supporting the development of targeted diagnostic and therapeutic strategies. Their ability to selectively target tumor tissue while keeping unwanted side-effects on healthy cells to a minimum makes them valuable tools for researchers investigating cancer biology and novel treatment approaches.
Among the most widely studied cancer-targeting peptides are RGD peptides, which bind integrin receptors involved in angiogenesis and tumor progression. In contrast, non-RGD peptides target a broader range of mechanisms, including tumor homing, cell penetration, intracellular pathways, and immune modulation.
Learn more on how to choose the right cancer peptide for you! RGD or non-RGD, scale, purity etc. – we support you along the way!
**For Research Use Only.** JPT's cancer peptides are intended exclusively for laboratory research and are not for diagnostic, therapeutic, or clinical applications.
Cancer Peptides Applications
The peptide's properties should align with your research goals, whether focused on:
- Tumor targeting
- Drug delivery
- Molecular imaging
- Immune modulation
Benefits of JPT Peptides
- High-throughput synthesis for scalable production
- Manufactured in Germany under stringent quality standards
- Flexible ordering options and purity levels
- Freeze-dried aliquots available for enhanced stability
- Comprehensive scientific support
- Cost-effective and scalable solutions
- Extensive modification and conjugation options through custom synthesis
- All catalog peptides are supplied with HPLC-MS analysis to verify identity and ensure consistently high product quality.
Explore JPT's Cancer Peptide Portfolio!
Our catalog includes both RGD and non-RGD peptides, featuring widely used examples such as: iRGD Cilengitide Cecropin A Bevacizumab-derived peptides
Our catalog offers so much more!
Beyond our portfolio of cancer-targeting peptides, JPT offers a comprehensive range of products supporting oncology research.
- PepMix™ Peptides Pools covering Tumor Associated Antigen (TAA)
- Single Antigen Peptides
- PepStar™ Peptide Microarrays covering TAAs
- Chelating DOTA peptides
- Radiosensitizer peptides
In addition, our custom peptide synthesis capabilities enable researchers to develop tailored peptide designs, conjugates, and modified sequences for specialized applications in oncology, immunology, and vaccine research.